Free tool

Diagnostics stocks

We cover 13 companies grouped under the Diagnostics theme. The median market value in the group is $3.56B. Across the group, the median move over the past trading day is −0.06%. Price change over the past year runs from −26.2% to +143.6% across the middle 80 percent of the group, with a median of +3.7%. Across the group, 1 company currently carries a tier A volume signal.

Other lists in this group

Table

13 of 150 companies match these filters.Clear filters

TickerCompanyMarket cap (USD)Size1Y returnNext report
QGENQiagen N.V.$9.01BMid cap−9.65%Nov 4, 2026
QIA.DEQiagen N.V.$8.99BMid cap−6.73%Nov 4, 2026
CAICaris Life Sciences, Inc.$7.58BMid cap−29.83%Nov 4, 2026
6869.TSysmex Corporation$7.28BMid cap+3.66%Nov 4, 2026
BLLNBillionToOne, Inc.$4.54BMid cap−11.68%Nov 5, 2026
ADPTAdaptive Biotechnologies Corporation$4.18BMid cap+101.70%Nov 4, 2026
VCYTVeracyte, Inc. Common Stock$3.56BMid cap+54.81%Nov 3, 2026
GRALGRAIL, Inc.$3.55BMid cap+136.66%Nov 11, 2026
WGSGeneDx Holdings Corp.$2.69BMid cap−30.11%Oct 27, 2026
CDNACareDx, Inc.$2.64BMid cap+283.45%Nov 3, 2026
NEOGNeogen Corporation$2.54BMid cap+103.83%Oct 8, 2026
NEONeoGenomics, Inc.$2.26BMid cap+145.34%Oct 27, 2026
ALIF-B.STAddLife AB (publ)$2.08BMid cap−7.20%Oct 21, 2026

Covers ~22,000 companies across the US, Europe and Asia-Pacific (ex mainland China, Hong Kong and India), refreshed nightly. Every listed stock opens as a full analysis for $9.90.

More ways to browse